Abstract Library

#4100 Pheochromocytoma and paraganglioma: Gender differences in lipid profile

Introduction: Pheochromocytoma and paraganglioma (PPGL) are rare neuroendocrine neoplasms potentially influencing lipid metabolism and increasing cardiovascular risk. Gender differences in PPGL are largely unknown.

Conference:

Presenting Author: Di Iasi G

Authors: Di Iasi G, Benevento E, Cannavale G, Liccardi A, Minotta R,

Keywords: gender, Pheochromocytoma, paraganglioma, lipid, cholesterol,

#3782 Somatostatin analogues (SSA) in gastroenteropancreatic neuroendocrine tumors (GEP-NET) – Impact on glycemia and lipid profile in a monocentric series

Introduction: Somatostatin analogues (SSA) are often the first line therapy in neuroendocrine tumors (NET). The management of hyperglycaemia and dyslipidaemia are one of the most important challenges in healthcare. The impact of SSA on metabolic profile in GEP-NET is highly debated.

Conference:

Presenting Author: Cannavale G

Authors: Cannavale G, Benevento E, Minotta R, Liccardi A, Modica R,

Keywords: SSA, lipid profile, glycemia, GEP-NET, hyperglycaemia, Somatostatin analogues,

#3696 The characteristics of serum lipid spectrum in PanNENs and its correlation with clinicopathological features and prognosis

Introduction: Although dyslipidemia has been proved to be related to the occurrence, development, and prognosis of various malignancies, its role in pancreatic neuroendocrine neoplasms (PanNENs) is still unknown.

Conference:

Presenting Author: Meng Y

Authors: Meng Y, Fan Z, Yang J, Li Y, Liu S,

Keywords: Hyperlipidaemia, Insulinoma, Lipid, Pancreatic neuroendocrine neoplasm,